肿瘤-话题@MedSci

#肿瘤#

664篇内容 | 20247人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=950784, encodeId=ef9a950e8400, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, objectTitle=药物性肝损伤基层诊疗指南（2019年）, objectType=guider, longId=12606, objectId=80f951c001996e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=80f951c001996e5a, replyNumber=0, likeNumber=58, createdTime=2021-03-24, rootId=0, userName=ms1000000686260508, userId=2c975456358, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80f951c001996e5a, moduleTitle=药物性肝损伤基层诊疗指南（2019年）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=80f951c001996e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=950519, encodeId=8b879505196e, content=<a href='/topic/show?id=d8104361d5' target=_blank style='color:#2F92EE;'>#CD73#</a>是<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>新靶点, objectTitle=肿瘤免疫新兴靶点之一：CD73/2a型腺苷受体, objectType=article, longId=159534, objectId=ca381595343e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201902/20190205202848494.png, objectUrl=/article/show_article.do?id=ca381595343e, replyNumber=0, likeNumber=131, createdTime=2021-03-23, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca381595343e, moduleTitle=肿瘤免疫新兴靶点之一：CD73/2a型腺苷受体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca381595343e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=949866, encodeId=b7af949866ab, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>学习到啦！, objectTitle=英国MHRA允许开展阿霉素“前药”AVA6000治疗实体瘤的临床试验, objectType=article, longId=207393, objectId=6e4620e39317, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021220/1613832353092_5295902.jpeg, objectUrl=/article/show_article.do?id=6e4620e39317, replyNumber=0, likeNumber=105, createdTime=2021-03-21, rootId=0, userName=九州安错, userId=5b0a5279477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e4620e39317, moduleTitle=英国MHRA允许开展阿霉素“前药”AVA6000治疗实体瘤的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e4620e39317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=949360, encodeId=5fbf9493602f, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>肿瘤患者的食补，学习了, objectTitle=肿瘤患者春节期间如何科学健康饮食？肿瘤人群饮食指导手册这里收藏了, objectType=article, longId=207083, objectId=548020e0833c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20210203/ab2d0325cd694ee28a43b2aa0f9f5915.jpg, objectUrl=/article/show_article.do?id=548020e0833c, replyNumber=1, likeNumber=165, createdTime=2021-03-18, rootId=0, userName=九州安错, userId=5b0a5279477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=548020e0833c, moduleTitle=肿瘤患者春节期间如何科学健康饮食？肿瘤人群饮食指导手册这里收藏了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=548020e0833c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=947240, encodeId=1d2994e2408a, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>每天都看看有没有新内容, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=56, createdTime=2021-03-10, rootId=0, userName=水-晶, userId=6f475314305, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=890670, encodeId=23f78906e022, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, objectTitle=AM J TRANSL RES, objectType=tool_impact_factor, longId=12338, objectId=b7df12338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/submit.do?id=b7df12338, replyNumber=2, likeNumber=657, createdTime=2020-10-09, rootId=0, userName=科研小王子66, userId=ecb62236224, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7df12338, moduleTitle=AM J TRANSL RES, moduleType=tool_impact_factor, hrefUrl=https://www.medsci.cn/sci/submit.do?id=b7df12338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=926818, encodeId=33dd92681856, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>临床型文章第一次投稿，2020.9.27投稿，期间因为各种原因约11月份送的外审，12.22 返修大改，2021.1.12提交后因为修改作者信息和杂志社沟通耽误了很久，最终2.22成功通过新的author list，第二天通知接受。投稿两点：一是注重文章创新性，二是千万不要临时添加作者，真的特别特别麻烦，前前后后发了有20封邮件。, objectTitle=CANCER MED-US, objectType=tool_impact_factor, longId=12643, objectId=a3c712643, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/journalcover/a3c712643.jpg, objectUrl=/sci/submit.do?id=a3c712643, replyNumber=2, likeNumber=472, createdTime=2021-02-24, rootId=0, userName=ms4000001388777051, userId=f7255341865, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c712643, moduleTitle=CANCER MED-US, moduleType=tool_impact_factor, hrefUrl=https://www.medsci.cn/sci/submit.do?id=a3c712643)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=946107, encodeId=decd94610e2f, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>好的, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2020.V2）, objectType=guider, longId=11997, objectId=02b101c001935874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=02b101c001935874, replyNumber=0, likeNumber=55, createdTime=2021-03-07, rootId=0, userName=ms2000001194856568, userId=ae0b5452553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b101c001935874, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2020.V2）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=02b101c001935874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=945757, encodeId=59ed945e5777, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, objectTitle=NEJM：Nivolumab联合Cabozantinib治疗晚期肾细胞癌, objectType=article, longId=207911, objectId=9b3720e91188, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/400x240.jpg, objectUrl=/article/show_article.do?id=9b3720e91188, replyNumber=0, likeNumber=106, createdTime=2021-03-05, rootId=0, userName=筱沐, userId=7e925465894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3720e91188, moduleTitle=NEJM：Nivolumab联合Cabozantinib治疗晚期肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b3720e91188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=944051, encodeId=b87a94405157, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>继续来进来看看了, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=68, createdTime=2021-02-27, rootId=0, userName=水-晶, userId=6f475314305, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=809271, encodeId=848d8092e13d, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, objectTitle=J CARDIOTHORAC SURG, objectType=tool_impact_factor, longId=10386, objectId=5af210386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/submit.do?id=5af210386, replyNumber=2, likeNumber=638, createdTime=2020-08-15, rootId=0, userName=Lei-Lei, userId=75b92509278, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5af210386, moduleTitle=J CARDIOTHORAC SURG, moduleType=tool_impact_factor, hrefUrl=https://www.medsci.cn/sci/submit.do?id=5af210386)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=943768, encodeId=9366943e6842, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>很受益, objectTitle=全球首创！康方生物PD-1/CTLA-4双抗治疗宫颈癌获美国FDA孤儿药认定, objectType=article, longId=207633, objectId=bf5620e63327, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021226/1614302555010_5295905.jpg, objectUrl=/article/show_article.do?id=bf5620e63327, replyNumber=0, likeNumber=112, createdTime=2021-02-26, rootId=0, userName=ms8000000022521331, userId=7b0f5463411, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf5620e63327, moduleTitle=全球首创！康方生物PD-1/CTLA-4双抗治疗宫颈癌获美国FDA孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf5620e63327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=926964, encodeId=c0a692696406, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>请问怎么获得投稿模板，跪求啊，或者如何投稿, objectTitle=CELL PROLIFERAT, objectType=tool_impact_factor, longId=1376, objectId=c3dc1376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/submit.do?id=c3dc1376, replyNumber=0, likeNumber=130, createdTime=2021-02-24, rootId=0, userName=ms1000001699156598, userId=cc305462860, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3dc1376, moduleTitle=CELL PROLIFERAT, moduleType=tool_impact_factor, hrefUrl=https://www.medsci.cn/sci/submit.do?id=c3dc1376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=926869, encodeId=3bb192686902, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>点点关注汇成知识海洋, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=57, createdTime=2021-02-24, rootId=0, userName=易水河, userId=66771693911, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=926732, encodeId=537b926e3250, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>每天进来看看你们的成果, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=60, createdTime=2021-02-23, rootId=0, userName=水-晶, userId=6f475314305, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=926245, encodeId=dc6d92624517, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>新的一年关注更多肿瘤进展, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=46, createdTime=2021-02-21, rootId=0, userName=水-晶, userId=6f475314305, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=925363, encodeId=408092536377, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>每天都来看看新内容, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=0, createdTime=2021-02-18, rootId=0, userName=水-晶, userId=6f475314305, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=924816, encodeId=55f7924816c1, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>希望早点攻克这个难题吧, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=63, createdTime=2021-02-15, rootId=0, userName=水-晶, userId=6f475314305, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=924774, encodeId=0175924e7401, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>希望改善生活质量，延长生命。, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=59, createdTime=2021-02-15, rootId=0, userName=言西早, userId=13511650672, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=924627, encodeId=64ed92462e79, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>每天都要进来看看了, objectTitle=肿瘤, objectType=topic, longId=82769, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020910/1599727738534_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=58, createdTime=2021-02-14, rootId=0, userName=水-晶, userId=6f475314305, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗癌大战，看这里

2020-05-29

ms1000000686260508 (审核中...)

前往app查看评论内容

#肿瘤#

药物性肝损伤基层诊疗指南（2019年）

2021-03-24

病毒猎手 (审核中...)

前往app查看评论内容

#CD73#是#肿瘤#新靶点

肿瘤免疫新兴靶点之一：CD73/2a型腺苷受体

2021-03-23

九州安错 (审核中...)

前往app查看评论内容

#肿瘤#学习到啦！

英国MHRA允许开展阿霉素“前药”AVA6000治疗实体瘤的临床试验

2021-03-21

九州安错 (审核中...)

前往app查看评论内容

#肿瘤#肿瘤患者的食补，学习了

肿瘤患者春节期间如何科学健康饮食？肿瘤人群饮食指导手册这里收藏了

2021-03-18

水-晶 (审核中...)

前往app查看评论内容

#肿瘤#每天都看看有没有新内容

2021-03-10

科研小王子66 (审核中...)

前往app查看评论内容

#肿瘤#非常不错的期刊，很友好

AM J TRANSL RES

2020-10-09

ms4000001388777051 (审核中...)

前往app查看评论内容

全文收起 #肿瘤#临床型文章第一次投稿，2020.9.27投稿，期间因为各种原因约11月份送的外审，12.22 返修大改，2021.1.12提交后因为修改作者信息和杂志社沟通耽误了很久，最终2.22成功通过新的author list，第二天通知接受。投稿两点：一是注重文章创新性，二是千万不要临时添加作者，真的特别特别麻烦，前前后后发了有20封邮件。

CANCER MED-US

2021-02-24

ms2000001194856568 (审核中...)

前往app查看评论内容

#肿瘤#好的

NCCN临床实践指南：B细胞淋巴瘤（2020.V2）

2021-03-07

筱沐 (审核中...)

前往app查看评论内容

#学习##肿瘤#

NEJM：Nivolumab联合Cabozantinib治疗晚期肾细胞癌

2021-03-05

水-晶 (审核中...)

前往app查看评论内容

#肿瘤#继续来进来看看了

2021-02-27

Lei-Lei (审核中...)

前往app查看评论内容

全文收起 #肿瘤#写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈

J CARDIOTHORAC SURG

2020-08-15

ms8000000022521331 (审核中...)

前往app查看评论内容

#学习##肿瘤#很受益

全球首创！康方生物PD-1/CTLA-4双抗治疗宫颈癌获美国FDA孤儿药认定

2021-02-26

ms1000001699156598 (审核中...)

前往app查看评论内容

#肿瘤#请问怎么获得投稿模板，跪求啊，或者如何投稿

CELL PROLIFERAT

2021-02-24

易水河 (审核中...)

前往app查看评论内容

#肿瘤#点点关注汇成知识海洋

2021-02-24

水-晶 (审核中...)

前往app查看评论内容

#肿瘤#每天进来看看你们的成果

2021-02-23

水-晶 (审核中...)

前往app查看评论内容

#肿瘤#新的一年关注更多肿瘤进展

2021-02-21

水-晶 (审核中...)

前往app查看评论内容

#肿瘤#每天都来看看新内容

2021-02-18

水-晶 (审核中...)

前往app查看评论内容

#肿瘤#希望早点攻克这个难题吧

2021-02-15

言西早 (审核中...)

前往app查看评论内容

#肿瘤#希望改善生活质量，延长生命。

2021-02-15

水-晶 (审核中...)

前往app查看评论内容

#肿瘤#每天都要进来看看了

2021-02-14

科室
- - 订阅+
  - 更多科室
工具
服务